Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05949242 · ClinicalTrials.gov registry record · NA

Clinical Outcomes in Cataract Surgery With OMNI Canaloplasty vs Cataract Surgery With OMNI Canaloplasty and Hydrus Stent

A NA study of Glaucoma Open-Angle, sponsored by Ridge Eye Care.

Active
Registry status
NA
Development phase
80
Enrollment target
4
Study locations

NCT05949242 is a NA study of Glaucoma Open-Angle that is active but no longer recruiting, run by Ridge Eye Care. The registered enrollment target is 80 participants, below the 162-participant average among 22 other Glaucoma Open-Angle trials with a reported enrollment target (51% lower). The trial reports 4 study locations across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05949242, a NA study of Glaucoma Open-Angle, is active but no longer recruiting, sponsored by Ridge Eye Care.

ACTIVE NOT RECRUITING
Registry status
NA
Development phase
80 participants
Enrollment target
4
Study locations

Study Summary

The goal of this clinical trial is to look at the difference in pressure lowering effects in patients having two different combinations of minimally invasive glaucoma surgery (MIGS) at the time of their cataract surgery. Eligible patients will have mild to moderate glaucoma and be candidates for cataract surgery. The trial will look at the eye pressure before and one year after cataract surgery in patients. One eye in each patient will have cataract surgery with canaloplasty using OMNI. The patients other eye will have cataract surgery with canaloplasty and a HYDRUS stent. The trial will look at the differences in eye pressure and if patients are able to need fewer eye pressure lowering drops after surgery. Study participants will undergo preop testing of pressure, vision, slit lamp exam, ocular coherence tomography (OCT) of the nerve fiber layer (NFL) analysis, and visual field prior to cataract surgery with MIGS. One day, one week, one month, 6 month, and 1 year exams will be performed to check pressure, vision, slit lamp exam, and number of necessary eye pressure medications in each eye.

Conditions Studied

Glaucoma Open-Angle

Interventions

  • DEVICE OMNI canaloplasty
  • DEVICE Hydrus microstent

Study Locations (4)

California

  • Royo Eye Care - Marysville
  • Table Mountain Eye Care - Oroville
  • Ridge Eye Institute - Paradise
  • Feather River Eye Care - Yuba City

Trial Details

FieldValue
Enrollment Target 80 participants
Start Date 2023-04-07
Est. Completion 2025-10
Phase NA

Sponsor

Ridge Eye Care

1 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT05949242

The ClinicalTrials.gov registry entry for NCT05949242 describes a study currently listed as active not recruiting, categorized as NA. The registered enrollment target is 80 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 162-participant average among 22 other Glaucoma Open-Angle trials with a reported enrollment target (51% lower). The listed sponsor is Ridge Eye Care, which has 1 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Glaucoma Open-Angle appearing as the primary indexed condition, and to 2 interventions - of which OMNI canaloplasty is the first listed.

NCT05949242 reports 4 study locations spanning 1 distinct geographic area - top geographies include California.

Frequently Asked Questions

What is clinical trial NCT05949242 about?

NCT05949242 is a clinical study titled "Clinical Outcomes in Cataract Surgery With OMNI Canaloplasty vs Cataract Surgery With OMNI Canaloplasty and Hydrus Stent". The goal of this clinical trial is to look at the difference in pressure lowering effects in patients having two different combinations of minimally invasive glaucoma surgery (MIGS) at the time of their cataract surgery. Eligible patients will have mild to moderate glaucoma and be candidates for cat...

What is the current status of trial NCT05949242?

This trial is currently active not recruiting. It is a NA study. The enrollment target is 80 participants. The study started on 2023-04-07. Estimated completion is 2025-10.

What conditions does trial NCT05949242 study?

This clinical trial studies the following conditions: Glaucoma Open-Angle.

What interventions are being tested in trial NCT05949242?

The interventions under investigation include: OMNI canaloplasty (DEVICE), Hydrus microstent (DEVICE).

Who is sponsoring clinical trial NCT05949242?

This trial is sponsored by Ridge Eye Care, which has 1 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05949242 being conducted?

This trial has 4 study locations across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Glaucoma Open-Angle

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Glaucoma Open-Angle

All registered trials for this condition

California

All trials with a study site in California

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.